ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CADL Candel Therapeutics Inc

8.90
0.47 (5.58%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Candel Therapeutics Inc CADL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.47 5.58% 8.90 14:00:12
Open Price Low Price High Price Close Price Previous Close
8.34 8.34 9.39 9.02 8.43
more quote information »

Recent News

Date Time Source Heading
25/4/202422:00GLOBECandel Therapeutics Announces Upcoming Presentations at the..
11/4/202423:00GLOBECandel Therapeutics Receives FDA Orphan Drug Designation for..
09/4/202422:00GLOBECandel Therapeutics Presents Preclinical Data at AACR on..
04/4/202423:00GLOBECandel Therapeutics Announces Positive Interim Data from..
29/3/202407:05GLOBECandel Therapeutics Announces Oral Presentation During the..
28/3/202423:05GLOBECandel Therapeutics Reports Fourth Quarter and Full Year..
07/3/202400:00EDGAR2Form 8-K - Current report
06/3/202408:30GLOBECandel Therapeutics Announces an Upcoming Presentation at..
14/2/202401:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/2/202423:45EDGAR2Form 8-K - Current report
13/2/202423:30GLOBECAN-3110 Receives FDA Fast Track Designation for Treatment..
06/2/202400:00GLOBECandel Therapeutics Sets Path to Success: Recent..
20/1/202400:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/1/202408:30EDGAR2Form 8-K - Current report
04/1/202400:30EDGAR2Form 8-K - Current report
13/12/202300:58DJNCandel Therapeutics Shares Soar After FDA Fast Track of..
13/12/202300:30EDGAR2Form 8-K - Current report
13/12/202300:00GLOBECandel Therapeutics Receives FDA Fast Track Designation for..
01/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202301:00EDGAR2Form 8-K - Current report
29/11/202301:00GLOBECandel Therapeutics Announces Restructuring to Prioritize..
22/11/202309:00EDGAR2Form 8-K - Current report
10/11/202300:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202300:16EDGAR2Form 8-K - Current report
10/11/202300:00GLOBECandel Therapeutics Reports Third Quarter 2023 Financial..
07/11/202300:53EDGAR2Form 8-K - Current report
07/11/202300:15EDGAR2Form 8-K - Current report
04/11/202323:00GLOBECandel Therapeutics Presents Preclinical Data from its..
04/11/202303:00GLOBECandel Therapeutics Announces Initial Positive Interim Data..
19/10/202302:31EDGAR2Form 8-K - Current report
19/10/202302:00GLOBECandel Therapeutics Announces Nature Publication Showing..
27/9/202323:40GLOBECandel Therapeutics Announces Three Abstracts Accepted for..
26/9/202322:30EDGAR2Form 8-K - Current report
26/9/202322:00GLOBECandel Therapeutics Reports Encouraging Initial Survival..
06/9/202322:00GLOBECandel Therapeutics to Participate in the H.C. Wainwright..
10/8/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:15EDGAR2Form 8-K - Current report
10/8/202322:00GLOBECandel Therapeutics Reports Second Quarter 2023 Financial..
02/8/202322:00GLOBECandel Therapeutics to Participate in the Canaccord Genuity..
29/6/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202322:31EDGAR2Form 8-K - Current report
13/6/202322:00GLOBECandel Therapeutics Announces It Expects to Report Topline..
08/6/202322:00GLOBECandel Therapeutics Appoints Experienced Manufacturing..

Your Recent History

Delayed Upgrade Clock